GM

Gerard Michel

Chief Executive Officer

Delcath Systems, Inc

Cambridge, Massachusetts


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Delcath Systems, Inc
Industry
pharmaceuticals
Employees
110.0
Seniority
C suite
Annual Revenue
37200000.0

Technologies

Outlook Backbone JS Library Adobe Marketing Cloud Remote AI

Keywords

oncology research development liver cancers ocular melanoma intrahepatic cholangiocarcinoma hepatocellular carcinoma uveal melanoma metastatic uveal melanoma hepatic dominant uveal melanoma liver directed therapy biotechnology life sciences medical/dental instruments health care pharmaceutical manufacturing interventional oncology liver cancer treatment hepzato kit chemosat minimally invasive procedures percutaneous hepatic perfusion targeted chemotherapy vascular isolation clinical trials fda approved treatment high-dose chemotherapy oncology device cancer therapies melphalan patient outcomes clinical studies drug delivery system hepatology cancer metastases medical devices cancer research patient care solutions compliance regulatory affairs clinical development oncology innovation treatment options surgical alternatives biologic therapies chemotherapy optimization tumor management quality assurance manufacturing processes supply chain management medical technology clinical efficacy safety monitoring patient support programs investor relations market analysis healthcare professionals biopharmaceuticals therapeutic strategies research & development healthcare accessibility hospital & health care health wellness & fitness pharmaceuticals medical logistics & supply chain

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans